ERBB2 and breast cancer: Since previous studies indicate that mTORC2 is required for survival of HER2-amplified breast cancer cells [10, 14], it is likely that the reduced metastases seen upon knockdown of Rictor are due to both a reduction in tumor cell survival and a reduction in tumor cell motility.